Dr. Andre Groenewegen, Managing Director of Rosemont Pharmaceuticals, Limited, BTG's wholly owned subsidiary in the UK, has been promoted to the additional post of Senior Vice President, Bio-Technology General Corp.Dr. Groenewegen joined the Company in September 2002 when BTG acquired Rosemont.
From 1996 through September 2002, he
held a number of positions within Akzo Nobel
and its various business units, including Vice President
, Rosemont Pharmaceuticals Corp.
, Director, Sales & Marketing
, Organon Belgium and Luxembourg
, and in the Strategy and Business Development Department of Organon International
.Dr. Groenewegen holds a medical degree from the State University of Utrecht, the Netherlands.